The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 1,565,500 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | |||
AEROVATE THERAPEUTICS INC | COM | 008064107 | 4,752,300 | 210,000 | SH | SOLE | 210,000 | 0 | 0 | |||
ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 5,263,775 | 27,500 | SH | SOLE | 27,500 | 0 | 0 | |||
AMBRX BIOPHARMA INC | COM | 641871108 | 6,764,000 | 475,000 | SH | SOLE | 475,000 | 0 | 0 | |||
AMYLYX PHARMACEUTICALS INC | COM | 03237H101 | 2,944,000 | 200,000 | SH | Call | SOLE | 200,000 | 0 | 0 | ||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 5,986,000 | 100,000 | SH | Call | SOLE | 100,000 | 0 | 0 | ||
ARGENX SE | SPONSORED ADR | 04016X101 | 5,706,450 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | |||
ARVINAS INC | COM | 04335A105 | 2,438,730 | 59,250 | SH | SOLE | 59,250 | 0 | 0 | |||
ASCENDIS PHARMA A/S | SPONSORED ADR | 04351P101 | 2,519,000 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | |||
ASTRIA THERAPEUTICS INC | COM | 04635X102 | 2,572,800 | 335,000 | SH | SOLE | 335,000 | 0 | 0 | |||
AXSOME THERAPEUTICS INC | COM | 05464T104 | 13,132,350 | 165,000 | SH | SOLE | 165,000 | 0 | 0 | |||
BIOHAVEN LTD | COM | G1110E107 | 11,770,000 | 275,000 | SH | SOLE | 275,000 | 0 | 0 | |||
BLUEBIRD BIO INC | COM | 09609G100 | 641,700 | 465,000 | SH | SOLE | 465,000 | 0 | 0 | |||
BRIDGEBIO PHARMA INC | COM | 10806X102 | 5,046,250 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | |||
CABALETTA BIO INC | COM | 12674W109 | 3,405,000 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | |||
COGENT BIOSCIENCES INC | COM | 19240Q201 | 1,146,600 | 195,000 | SH | SOLE | 195,000 | 0 | 0 | |||
CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 2,312,700 | 65,000 | SH | SOLE | 65,000 | 0 | 0 | |||
CYMABAY THERAPEUTICS INC | COM | 23257D103 | 2,125,800 | 90,000 | SH | SOLE | 90,000 | 0 | 0 | |||
CYTOKINETICS INC | COM NEW | 23282W605 | 834,900 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | |||
CYTOKINETICS INC | COM NEW | 23282W605 | 6,679,200 | 80,000 | SH | Call | SOLE | 80,000 | 0 | 0 | ||
DECIPHERA PHARMACEUTICALS IN | COM | 24344T101 | 3,629,250 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | |||
EYEPOINT PHARMACEUTICALS INC | COM NEW | 30233G209 | 3,813,150 | 165,000 | SH | SOLE | 165,000 | 0 | 0 | |||
INHIBRX INC | COM | 45720L107 | 1,330,000 | 35,000 | SH | SOLE | 35,000 | 0 | 0 | |||
ISHARES TR | RUSSELL 2000 ETF | 464287655 | 50,177,500 | 250,000 | SH | Call | SOLE | 250,000 | 0 | 0 | ||
KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 1,592,941 | 130,036 | SH | SOLE | 130,036 | 0 | 0 | |||
KRYSTAL BIOTECH INC | COM | 501147102 | 6,203,000 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | |||
MADRIGAL PHARMACEUTICALS INC | COM | 558868105 | 3,470,700 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | |||
MARINUS PHARMACEUTICALS INC | COM NEW | 56854Q200 | 1,467,450 | 135,000 | SH | SOLE | 135,000 | 0 | 0 | |||
MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | 61559X104 | 4,831,200 | 80,000 | SH | SOLE | 80,000 | 0 | 0 | |||
MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | 61559X104 | 15,097,500 | 250,000 | SH | Call | SOLE | 250,000 | 0 | 0 | ||
NATERA INC | COM | 632307104 | 2,192,400 | 35,000 | SH | SOLE | 35,000 | 0 | 0 | |||
PERSPECTIVE THERAPEUTICS INC | COM | 46489V104 | 643,200 | 1,600,000 | SH | SOLE | 1,600,000 | 0 | 0 | |||
PHATHOM PHARMACEUTICALS INC | COM | 71722W107 | 3,517,250 | 385,241 | SH | SOLE | 385,241 | 0 | 0 | |||
PMV PHARMACEUTICALS INC | COM | 69353Y103 | 2,247,500 | 725,000 | SH | SOLE | 725,000 | 0 | 0 | |||
PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 2,866,250 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | |||
REPLIMUNE GROUP INC | COM | 76029N106 | 3,372,000 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | |||
REVANCE THERAPEUTICS INC | COM | 761330109 | 3,296,250 | 375,000 | SH | SOLE | 375,000 | 0 | 0 | |||
REVOLUTION MEDICINES INC | COM | 76155X100 | 2,151,000 | 75,000 | SH | Put | SOLE | 75,000 | 0 | 0 | ||
ROIVANT SCIENCES LTD | SHS | G76279101 | 6,738,000 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | |||
SAREPTA THERAPEUTICS INC | COM | 803607100 | 9,643,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | |||
SAVARA INC | COM | 805111101 | 3,525,000 | 750,000 | SH | SOLE | 750,000 | 0 | 0 | |||
SOLENO THERAPEUTICS INC | COM | 834203309 | 4,523,496 | 112,385 | SH | SOLE | 112,385 | 0 | 0 | |||
SPDR SER TR | S&P BIOTECH | 78464A870 | 22,322,500 | 250,000 | SH | Call | SOLE | 250,000 | 0 | 0 | ||
SPDR SER TR | S&P BIOTECH | 78464A870 | 26,787,000 | 300,000 | SH | Put | SOLE | 300,000 | 0 | 0 | ||
STRUCTURE THERAPEUTICS INC | SPONSORED ADS | 86366E106 | 6,114,000 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | |||
TARSUS PHARMACEUTICALS INC | COM | 87650L103 | 6,075,000 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | |||
TAYSHA GENE THERAPIES INC | COM SHS | 877619106 | 3,717,000 | 2,100,000 | SH | SOLE | 2,100,000 | 0 | 0 | |||
TG THERAPEUTICS INC | COM | 88322Q108 | 4,270,000 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | |||
UNIQURE NV | SHS | N90064101 | 1,117,050 | 165,000 | SH | SOLE | 165,000 | 0 | 0 | |||
VAXCYTE INC | COM | 92243G108 | 4,396,000 | 70,000 | SH | SOLE | 70,000 | 0 | 0 | |||
VERONA PHARMA PLC | SPONSORED ADS | 925050106 | 596,400 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | |||
VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 6,534,000 | 300,000 | SH | SOLE | 300,000 | 0 | 0 |